BUSINESS OF BIOTECH
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
BUSINESS OF BIOTECH
-
Lu par :
-
De :
À propos de ce contenu audio
In this bonus episode, which concludes the first series of the ‘Life Sci Fantastic’, Eliot steps back from examining the science of biotech to look at the business of this rapidly developing industry.
Eliot asks, what is driving those entrepreneurs to bring new treatments to patients, and what are the financial challenges in bringing these drugs to market?
Answering those questions is Bill Hicks, who has brokered deals and helped numerous companies and individuals chart the legal and financial challenges in the industry.
As co-chair of the life sciences practice at the US law firm Mintz, Bill has ridden the highs and lows of drug development, finance, stock market fluctuations, and more. In his conversation with Eliot, he reflects upon the business of bio-tech.
Host: Eliot Forster
Production team: Andy Coulson and Jane Sankey (Coulson Partners) and Richard Miron (Earshot Strategies)
With special thanks to Mintz - https://www.mintz.com
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !
